Reuters logo
BRIEF-Sunesis Pharma announces withdrawal of European MAA for vosaroxin
2017年5月1日 / 晚上9点02分 / 5 个月前

BRIEF-Sunesis Pharma announces withdrawal of European MAA for vosaroxin

May 1 (Reuters) - Sunesis Pharmaceuticals Inc:

* Sunesis Pharmaceuticals announces withdrawal of European Marketing Authorization Application (MAA) for vosaroxin as a treatment for relapsed/refractory AML

* Sunesis Pharmaceuticals Inc says expect that current cash resources are sufficient to fund company beyond Q1 2018

* Sunesis Pharmaceuticals - significantly reducing investment in AML program & shifting an increasing portion of resources to kinase inhibitor pipeline Source text for Eikon: Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below